MarketCap
Amphastar Pharmaceuticals AMPH
€ 24.46
-1.61%
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2014 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
46.7 M |
Marktkapitalisierung |
$ 1.29 B |
EBITDA (LTM) |
$ 182 M |
P/E (LTM) |
12.244444 |
P/S (LTM) |
1.726726 |
EPS (LTM) |
2.25 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
PolyPid Ltd.
PYPD
|
$ 5.8 | -0.34 % | $ 94.8 M | Nasdaq Global Select Market |  Israel |
 |
Summit Therapeutics
SMMT
|
$ 14.17 | -12.37 % | $ 10.6 B | Nasdaq Global Select Market |  Britain |
 |
Outlook Therapeutics
OTLK
|
$ 0.44 | -4.63 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
uniQure N.V.
QURE
|
$ 20.96 | -9.01 % | $ 1.21 B | Nasdaq Global Select Market |  Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 15.55 | -9.38 % | $ 1.53 B | Nasdaq Global Select Market,SPB | USA |
 |
Rafael Holdings
RFL
|
$ 1.06 | -4.5 % | $ 54.5 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 7.37 | -4.47 % | $ 380 M | Nasdaq Global Select Market,SPB | USA |
 |
Sanofi
SNY
|
$ 46.87 | -1.26 % | $ 57.2 B | Nasdaq Global Select Market |  France |
 |
Rigel Pharmaceuticals
RIGL
|
$ 45.56 | -11.17 % | $ 819 M | Nasdaq Global Select Market | USA |
 |
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | USA |
 |
Генетико
GECO
|
- | - | - | MOEX |  Russia |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Tenax Therapeutics
TENX
|
$ 1.65 | -8.84 % | $ 64.7 M | Nasdaq Global Select Market | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | France |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Scholar Rock Holding Corporation
SRRK
|
$ 45.27 | -1.78 % | $ 5.19 B | Nasdaq Global Select Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market |  Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
- | 0.74 % | $ 768 M | Nasdaq Capital Market | Israel |
 |
Abcam plc
ABCM
|
- | - | $ 4.9 B | Nasdaq Global Select Market | Britain |
 |
Rezolute
RZLT
|
$ 3.65 | -7.95 % | $ 379 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
Tiziana Life Sciences PLC
TLSA
|
$ 0.62 | -2.71 % | $ 66.1 M | Nasdaq Global Market | Britain |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | Germany |
 |
Affimed N.V.
AFMD
|
- | -34.95 % | $ 21.5 M | Nasdaq Global Select Market,SPB | Germany |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 1.72 | 1.04 % | $ 1.16 B | Nasdaq Capital Market | Israel |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
- | -1.58 % | $ 28.1 M | Nasdaq Global Market | China |
 |
Celyad Oncology SA
CYAD
|
- | - | $ 12.5 M | Nasdaq Global Market |  Belgium |
 |
Seer
SEER
|
$ 1.63 | -4.12 % | $ 90.3 M | Nasdaq Global Select Market | USA |
 |
Gracell Biotechnologies
GRCL
|
- | - | $ 3.37 B | Nasdaq Global Select Market | China |
 |
Trevi Therapeutics
TRVI
|
$ 12.8 | -8.47 % | $ 1.72 B | Nasdaq Global Market | USA |
|
Silence Therapeutics plc
SLN
|
$ 19.73 | -0.35 % | $ 2.8 B | Nasdaq Global Select Market | Britain |
 |
Soligenix
SNGX
|
$ 0.33 | -5.02 % | $ 1.71 M | Nasdaq Capital Market | USA |
 |
Spruce Biosciences
SPRB
|
$ 42.5 | -8.82 % | $ 32.6 M | Nasdaq Global Select Market | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 26.77 | -5.1 % | $ 1.51 B | Nasdaq Global Select Market,SPB | USA |
 |
Galapagos NV
GLPG
|
- | - | $ 1.83 B | Nasdaq Global Select Market | Belgium |
 |
Savara
SVRA
|
$ 4.33 | -7.06 % | $ 963 M | Nasdaq Global Select Market | USA |
 |
Teligent, Inc.
TLGT
|
- | -13.85 % | $ 16.1 M | Nasdaq Global Select Market | USA |
 |
Viela Bio, Inc.
VIE
|
- | - | $ 2.91 B | Nasdaq Global Select Market | USA |
 |
Gilead Sciences
GILD
|
$ 167.62 | -3.93 % | $ 209 B | Nasdaq Global Select Market,SPB | USA |
 |
TG Therapeutics
TGTX
|
$ 58.02 | -5.86 % | $ 8.37 B | Nasdaq Capital Market | USA |
 |
Vir Biotechnology
VIR
|
$ 11.01 | -6.5 % | $ 1.53 B | Nasdaq Global Select Market,SPB | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.17 | -10.2 % | $ 6.47 M | Nasdaq Global Select Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 3.6 | -7.22 % | $ 212 M | Nasdaq Global Select Market,SPB | USA |
 |
Aphria Inc.
APHA
|
- | -0.45 % | $ 4.87 B | Nasdaq Global Select Market |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
- | -0.90 % | $ 104 M | Nasdaq Capital Market | USA |
 |
Chiasma, Inc.
CHMA
|
- | -6.00 % | $ 238 M | Nasdaq Global Select Market | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 3.2 | -11.19 % | $ 540 M | Nasdaq Global Select Market |  Singapore |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
- | - | $ 376 M | Nasdaq Global Market | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
- | 0.38 % | $ 12.9 M | Nasdaq Global Select Market | Israel |